免疫印迹法与间接免疫荧光法检测抗核抗体对照分析_张铁汉.pdf

568 CHINA ROPICAL MED ICINE Vol8 No4 April 2008 2008 8 4 5% ~ 17% (CIN ) ; . LC CIN, 24% ~ 94% ASC - H ASC FDA LC , , 0. 1% ~ 0. 2% , , LC , ASC- US ASC - H ASC 90% , 10% , ASC - H , 40 ASC - H , , CIN 14, 35% ; 417 ASC- US, , , CIN 34, 8. 15% , ASC - H , 2 CIN ASC- US, 2 , ( = 59. 17, P 0. 01) ASC ASC : , [ 1] Herbest AL. he Bethesda system for reporting cervical/vaginal cyto ASC- USIUD ( 3~ 6 logical diagnoses[ J]. Clin Obstet Gynecol, 1992, 35( 1): 22~ 27. ), CIN, [ 2] . [M ]. : , 2005, 3. , ASC - US [ 3] Hutchinson, et a.l U tility of liquid- based cytology for cerv ical carci nom a screening results of a population- based study conducted in a re , g ion of costa R ica w ith a high incidence of cervical carcinom a[ J]. , , ASC - US Cancer, 1999, 48~ 5, 87~ 89. 3% ~ 5% 4. 23% , [ 4] AnjaliL inaye, et al. Comparative analysis of conventionalPapanicolaou , tests and a fluid- based thin- layer m ethod A rch Pathol Lab Med, , , 2003, 127( 2): 200~ 204. , HPV [ 5] . BS[ J]. , ASC , 2003,